Dierk Wieckhusen

Title: Dierk Wieckhusen: Innovator in Injectable Depot Formulations

Introduction

Dierk Wieckhusen is a notable inventor based in Binzen, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of injectable depot formulations. With a total of 6 patents to his name, Wieckhusen's work has advanced the understanding and application of drug delivery systems.

Latest Patents

One of Wieckhusen's latest patents focuses on an injectable depot formulation comprising crystals of iloperidone. This formulation includes crystals with a specific structure, where the X50 value of the crystals ranges from 1 to 200 microns. The advantages of these depot formulations are noteworthy. They allow for the correlation of crystal release and absorption in plasma with the size of the crystals. Additionally, the particle size can be controlled through crystal engineering and milling techniques. Importantly, these crystals demonstrate stability during storage and are resilient to sterilization procedures, such as gamma irradiation.

Career Highlights

Throughout his career, Dierk Wieckhusen has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Wieckhusen has collaborated with several professionals in his field, including Sabine Pfeffer and Alexandra Glausch. These collaborations have likely enriched his research and development efforts.

Conclusion

Dierk Wieckhusen's innovative work in injectable depot formulations has made a significant impact on the pharmaceutical industry. His patents reflect a commitment to improving drug delivery systems, showcasing his expertise and dedication to advancing medical science.